These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2610905)

  • 1. A simple flow injection analysis for studies of drug-protein binding interactions in serum.
    Gizurarson S; Jensen A; Foss S
    Acta Pharm Nord; 1989; 1(5):291-4. PubMed ID: 2610905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of a capillary electrophoresis/frontal analysis (CE/FA) method for determining binding constants: discussion on relevant parameters.
    Vuignier K; Schappler J; Veuthey JL; Carrupt PA; Martel S
    J Pharm Biomed Anal; 2010 Dec; 53(5):1288-97. PubMed ID: 20719455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-protein interactions.
    Zia H
    Pahlavi Med J; 1978 Jul; 9(3):240-9. PubMed ID: 362352
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug displacement from protein-binding and redistributional interactions.
    McQueen EG
    Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
    [No Abstract]   [Full Text] [Related]  

  • 5. Single run measurements of drug-protein binding by high-performance frontal analysis capillary electrophoresis and mass spectrometry.
    Wan H; Ostlund A; Jönsson S; Lindberg W
    Rapid Commun Mass Spectrom; 2005; 19(12):1603-10. PubMed ID: 15915447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug interactions through influencing plasma-protein binding].
    Ohnhaus EE
    Internist (Berl); 1979 May; 20(5):225-8. PubMed ID: 376478
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding of drugs during and after pregnancy in rats.
    Stock B; Dean M; Levy G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):264-8. PubMed ID: 7351638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L; Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug binding to plasma proteins.
    Paxton JW
    N Z Med J; 1985 Apr; 98(776):245-8. PubMed ID: 3857503
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-protein interactions and their clinical significance.
    Gabourel JD
    Adv Biol Skin; 1972; 12():51-60. PubMed ID: 4579205
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis.
    Keller F; Wilms H; Schultze G; Offerman G; Molzahn M
    Clin Nephrol; 1983 Apr; 19(4):201-5. PubMed ID: 6851257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug plasma protein binding and pharmacokinetics].
    Han GZ; Liu YH
    Sheng Li Ke Xue Jin Zhan; 1987 Jul; 18(3):241-5. PubMed ID: 3313711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions of drugs with blood components and proteins].
    Tillement JP
    Ann Pharm Fr; 1988; 46(5):291-300. PubMed ID: 3256263
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma drug concentrations in therapeutics.
    Hooper WD; Tyrer JH; Eadie MJ
    Med J Aust; 1976 Mar; 1(10):313-9. PubMed ID: 1272103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.